2,084
Views
2
CrossRef citations to date
0
Altmetric
Review

Abdominal obesity increases the risk of reflux esophagitis: a systematic review and meta-analysis

ORCID Icon, , , , , , , , ORCID Icon & show all
Pages 131-142 | Received 14 Aug 2021, Accepted 12 Oct 2021, Published online: 05 Nov 2021

References

  • Richter JE, Rubenstein JH. Presentation and epidemiology of gastroesophageal reflux disease. Gastroenterology. 2018;154(2):267–276.
  • El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63(6):871–880.
  • Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology. 2019;156(1):254–272.e11.
  • Herbella FAM, Schlottmann F, Patti MG. Pathophysiology of gastroesophageal reflux disease: how an antireflux procedure works (or does not work). Updates Surg. 2018;70(3):343–347.
  • Menezes MA, Herbella FAM. Pathophysiology of gastroesophageal reflux disease. World J Surg. 2017;41(7):1666–1671.
  • Usai Satta P, Oppia F, Cabras F. Overview of pathophysiological features of GERD. Minerva Gastroenterol Dietol. 2017;63(3):184–197.
  • Spechler SJ, Souza RF. Barrett’s esophagus. N Engl J Med. 2014;371(9):836–845.
  • Schlottmann F, Dreifuss NH, Patti MG. Obesity and esophageal cancer: GERD, Barrett’s esophagus, and molecular carcinogenic pathways. Expert Rev Gastroenterol Hepatol. 2020;14(6):425–433.
  • Eusebi LH, Ratnakumaran R, Yuan Y, et al. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut. 2018;67(3):430–440.
  • Tchernof A, Després JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93(1):359–404.
  • Nadaleto BF, Herbella FA, Patti MG. Gastroesophageal reflux disease in the obese: pathophysiology and treatment. Surgery. 2016;159(2):475–486.
  • Singh S, Sharma AN, Murad MH, et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clinical gastroenterology and hepatology: the official clinical practice journal of the. Clin Gastroenterol Hepatol. 2013;11(11):1399–1412.e7.
  • Corley DA, Kubo A, Zhao W. Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut. 2007;56(6):756–762.
  • Nam SY, Choi IJ, Nam BH, et al. Obesity and weight gain as risk factors for erosive oesophagitis in men. Aliment Pharmacol Ther. 2009;29(9):1042–1052.
  • Mulholland HG, Cantwell MM, Anderson LA, et al. Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett’s esophagus, and esophageal adenocarcinoma. Cancer Causes Control. 2009;20(3):279–288.
  • Sogabe M, Okahisa T, Yamanoi A, et al. Subtypes of metabolic syndrome and of other risk factors in Japanese women with erosive esophagitis. Medicine. 2014;93(28):e276.
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (Clin Res Ed). 2009;339(Jul21 1):b2535–b2535.
  • Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Oxford; 2000.
  • Rostom A, Dubé C, Cranney A, et al. Appendix D. Quality assessment forms. In: Celiac disease. Agency for healthcare research and quality (US). Rockville, MD: Agency for Healthcare Research and Quality; 2004.
  • Shor E, Roelfs D, Vang ZM. The “Hispanic mortality paradox” revisited: meta-analysis and meta-regression of life-course differentials in Latin American and Caribbean immigrants' mortality. Soc Sci Med. 2017;186:20–33.
  • VanderWeele TJ. On a square-root transformation of the odds ratio for a common outcome. Epidemiology. 2017;28(6):e58–e60.
  • Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135(11):1301–1309.
  • Mazzoleni F, Mazzoleni LE, de Magalhães Francesconi CF, et al. Potential roles of Helicobacter pylori treatment, body mass index and waist circumference in the causation of erosive esophagitis: a randomized clinical trial (HEROES-GERD). Int J Obes (Lond). 2020;44(1):147–158.
  • Yang HJ, Chang Y, Park SK, et al. Sex differences in the relation between waist circumference within the normal range and development of reflux esophagitis. JCM. 2019;8(1):67.
  • Kim TJ, Lee H, Baek SY, et al. Metabolically healthy obesity and the risk of erosive esophagitis: a cohort study. Clin Transl Gastroenterol. 2019;10(9):e00077.
  • Hsieh YH, Wu MF, Yang PY, et al. What is the impact of metabolic syndrome and its components on reflux esophagitis? A cross-sectional study. BMC Gastroenterol. 2019;19(1):33.
  • Baeg MK, Ko SH, Ko SY, et al. Obesity increases the risk of erosive esophagitis but metabolic unhealthiness alone does not: a large-scale cross-sectional study. BMC Gastroenterol. 2018;18(1):82.
  • Ze EY, Kim BJ, Kang H, et al. Abdominal visceral to subcutaneous adipose tissue ratio is associated with increased risk of erosive esophagitis. Dig Dis Sci. 2017;62(5):1265–1271.
  • Lee SW, Lien HC, Lee TY, et al. Impact of obesity on a Chinese population with erosive esophagitis and Barrett’s esophagus. Gut Liver. 2017;11(3):377–382.
  • Hung WC, Wu JS, Yang YC, et al. Nonalcoholic fatty liver disease vs. obesity on the risk of erosive oesophagitis. Eur J Clin Invest. 2014;44(12):1143–1149.
  • Loke SS, Yang KD, Chen KD, et al. Erosive esophagitis associated with metabolic syndrome, impaired liver function, and dyslipidemia. WJG. 2013;19(35):5883–5888.
  • Jung JG, Kang HW, Hahn SJ, et al. Vegetarianism as a protective factor for reflux esophagitis: a retrospective, cross-sectional study between Buddhist priests and general population. Dig Dis Sci. 2013;58(8):2244–2252.
  • Sogabe M, Okahisa T, Kimura Y, et al. Visceral fat predominance is associated with erosive esophagitis in Japanese men with metabolic syndrome. Eur J Gastroenterol Hepatol. 2012;24(8):910–916.
  • Chiba H, Gunji T, Sato H, et al. A cross-sectional study on the risk factors for erosive esophagitis in young adults. Intern Med. 2012;51(11):1293–1299.
  • Wu P, Ma L, Dai GX, et al. The association of metabolic syndrome with reflux esophagitis: a case-control study. Neurogastroenterology and motility: the official journal of the. Eur Gastrointest Motil Soc. 2011;23(11):989–994.
  • Nam SY, Choi IJ, Ryu KH, et al. Abdominal visceral adipose tissue volume is associated with increased risk of erosive esophagitis in men and women. Gastroenterology. 2010;139(6):1902–1911.e2.
  • Koo JS, Lee SW, Park SM, et al. Abdominal obesity as a risk factor for the development of erosive esophagitis in subjects with a normal esophago-gastric junction. Gut Liver. 2009;3(4):276–284.
  • Chua CS, Lin YM, Yu FC, et al. Metabolic risk factors associated with erosive esophagitis. J Gastroenterol Hepatol. 2009;24(8):1375–1379.
  • Park JH, Park DI, Kim HJ, et al. Metabolic syndrome is associated with erosive esophagitis. WJG. 2008;14(35):5442–5447.
  • Lee HL, Eun CS, Lee OY, et al. Association between GERD-related erosive esophagitis and obesity. J Clin Gastroenterol. 2008;42(6):672–675.
  • Chung SJ, Kim D, Park MJ, et al. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case–control study of 7078 Koreans undergoing health check-ups. Gut. 2008;57(10):1360–1365.
  • Kang MS, Park DI, Oh SY, et al. Abdominal obesity is an independent risk factor for erosive esophagitis in a Korean population. J Gastroenterol Hepatol. 2007;22(10):1656–1661.
  • Takahashi K, Seki Y, Kasama K, et al. Prevalence of reflux esophagitis in obese Japanese undergoing bariatric surgery. JGH Open. 2020;4(3):519–524.
  • Tae CH, Jung HK, Kim SE, et al. Potential involvement of adiponectin in obesity-associated erosive esophagitis. J Clin Biochem Nutr. 2020;67(2):206–213.
  • Chung TH, Lee J, Jeong ID, et al. Effect of weight changes on the development of erosive esophagitis. Korean J Fam Med. 2020;41(1):14–19.
  • Nam SY, Kim YW, Park BJ, et al. Effect of abdominal visceral fat change on the regression of erosive esophagitis: a prospective cohort study. Gut Liver. 2019;13(1):25–31.
  • Rafat MN, Younus HA, El-Shorpagy MS, et al. Adiponectin level changes among Egyptians with gastroesophageal reflux disease. JGH Open: Open Access J Gastroenterol Hepatol. 2018;2(1):21–27.
  • Bang KB, Park JH. Weight loss as a nonpharmacologic strategy for erosive esophagitis: a 5-year follow-up study. Gut Liver. 2018;12(6):633–640.
  • Park JK, Lim Y, Lee H, et al. Comparison of anthropometric measurements associated with the risk of endoscopic erosive esophagitis: a cross-sectional study. Obes Res Clin Pract. 2017;11(6):694–702.
  • Nam SY, Kim YW, Park BJ, et al. Effect of abdominal visceral fat on the development of new erosive oesophagitis: a prospective cohort study. Eur J Gastroenterol Hepatol. 2017;29(4):388–395.
  • Hung WC, Wu JS, Sun ZJ, et al. Gender differences in the association of non-alcoholic fatty liver disease and metabolic syndrome with erosive oesophagitis: a cross-sectional study in a Taiwanese population. BMJ Open. 2016;6(11):e013106.
  • Chung H, Chon YE, Kim SU, et al. Noninvasive prediction of erosive esophagitis using a controlled attenuation parameter (CAP)-based risk estimation model. Dig Dis Sci. 2016;61(2):507–516.
  • Matsuzaki J, Suzuki H, Kobayakawa M, et al. Association of visceral fat area, smoking, and alcohol consumption with reflux esophagitis and Barrett’s esophagus in Japan. PLoS One. 2015;10(7):e0133865.
  • Wu YW, Tseng PH, Lee YC, et al. Association of esophageal inflammation, obesity and gastroesophageal reflux disease: from FDG PET/CT perspective. PLoS One. 2014;9(3):e92001.
  • Wu P, Zhao XH, Ai ZS, et al. Dietary intake and risk for reflux esophagitis: a case–control study. Gastroenterol Res Pract. 2013;2013:691026.
  • Mokrowiecka A, Daniel P, Jasinska A, et al. Serum adiponectin, resistin, leptin concentration and central adiposity parameters in Barrett’s esophagus patients with and without intestinal metaplasia in comparison to healthy controls and patients with GERD. Hepato-gastroenterology. 2012;59(120):2395–2399.
  • Hsu CS, Wang PC, Chen JH, et al. Increasing insulin resistance is associated with increased severity and prevalence of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2011;34(8):994–1004.
  • Gunji T, Sato H, Iijima K, et al. Risk factors for erosive esophagitis: a cross-sectional study of a large number of Japanese males. J Gastroenterol. 2011;46(4):448–455.
  • Chung SJ, Lim SH, Choi J, et al. Helicobacter pylori serology inversely correlated with the risk and severity of reflux esophagitis in Helicobacter pylori endemic area: a matched case–control study of 5,616 health check-up Koreans. J Neurogastroenterol Motil. 2011;17(3):267–273.
  • Tai CM, Lee YC, Tu HP, et al. The relationship between visceral adiposity and the risk of erosive esophagitis in severely obese Chinese patients. Obesity (Silver Spring). 2010;18(11):2165–2169.
  • Lee HL, Eun CS, Lee OY, et al. Association between erosive esophagitis and visceral fat accumulation quantified by abdominal CT scan. J Clin Gastroenterol. 2009;43(3):240–243.
  • Kato M, Watabe K, Hamasaki T, et al. Association of low serum adiponectin levels with erosive esophagitis in men: an analysis of 2405 subjects undergoing physical check-ups. J Gastroenterol. 2011;46(12):1361–1367.
  • Camilleri M, Malhi H, Acosta A. Gastrointestinal complications of obesity. Gastroenterology. 2017;152(7):1656–1670.
  • Chang P, Friedenberg F. Obesity and GERD. Gastroenterol Clin North Am. 2014;43(1):161–173.
  • McColl KEL. What is causing the rising incidence of esophageal adenocarcinoma in the West and will it also happen in the East? J Gastroenterol. 2019;54(8):669–673.
  • Mitchell DR, Derakhshan MH, Wirz AA, et al. Abdominal compression by waist belt aggravates gastroesophageal reflux, primarily by impairing esophageal clearance. Gastroenterology. 2017;152(8):1881–1888.
  • Lee YY, McColl KE. Disruption of the gastroesophageal junction by central obesity and waist belt: role of raised intra-abdominal pressure. Dis Esophagus. 2015;28(4):318–325.
  • Yarandi SS, Hebbar G, Sauer CG, et al. Diverse roles of leptin in the gastrointestinal tract: modulation of motility, absorption, growth, and inflammation. Nutrition. 2011;27(3):269–275.
  • Gyawali CP, Fass R. Management of gastroesophageal reflux disease. Gastroenterology. 2018;154(2):302–318.
  • Fass R. Alternative therapeutic approaches to chronic proton pump inhibitor treatment. Clin Gastroenterol Hepatol. 2012;10(4):338–345. Quiz e39–40.
  • Alamuddin N, Bakizada Z, Wadden TA. Management of obesity. J Clin Oncol. 2016;34(35):4295–4305.
  • Lear SA, Kohli S, Bondy GP, et al. Ethnic variation in fat and lean body mass and the association with insulin resistance. J Clin Endocrinol Metab. 2009;94(12):4696–4702.
  • Lear SA, Humphries KH, Kohli S, et al. Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr. 2007;86(2):353–359.